VPC
TECX

Vestal Point Capital’s Tectonic Therapeutic TECX Stock Holding History

Vestal Point Capital’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.6M Buy
425,000
+97,000
+30% +$2.85M 0.34% 49
2026
Q1 		$10.1M Hold
328,000
– – 0.28% 64
2025
Q4 		$6.84M Buy
+328,000
New +$6.1M 0.23% 55

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Vestal Point Capital's TECX Position: Q2 2026 in Review

Vestal Point Capital increased its Tectonic Therapeutic (TECX) stake by 30% in Q2 2026, buying an estimated $2.85M and bringing the position to 425,000 shares worth $14.6M. The position accounts for 0.34% of the portfolio, ranked #49.

Vestal Point Capital first reported a position in TECX in Q4 2025 and has held it in 3 quarters since. 123 funds tracked by Wall St. Rank hold TECX as of Q2 2026.

  • Vestal Point Capital held 425,000 shares of Tectonic Therapeutic worth $14.6M as of Q2 2026.
  • Vestal Point Capital bought 97,000 Tectonic Therapeutic shares in Q2 2026, an estimated $2.85M.
  • Tectonic Therapeutic made up 0.34% of Vestal Point Capital's portfolio in Q2 2026, its #49 holding.
  • Vestal Point Capital first reported a position in Tectonic Therapeutic in Q4 2025 and has held it in 3 quarters since.
  • 123 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.

Based on Vestal Point Capital's 13F filing for Q2 2026, filed 14 Aug 2026.